Medicare Part D coverage expansion: The proposed CMS rule allowing Medicare Part D plans to cover anti-obesity medications would make 31 million Medicare beneficiaries with obesity eligible for semaglutide and tirzepatide, representing a USD 55.8 billion annual drug spend potential at 15% initial penetration
Thus, our department has been a pioneer in utilizing these drugs since the early evidence demonstrated their efficacy
What purity does Retatrutide ship at, and what does the COA confirm?+ Retatrutide ships at a typical HPLC purity of 98%
Back Zander, M, Madsbad, S, Madsen, JL, Holst, JJ (9 March 2002) 'Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study', The Lancet , 359/9309, 824-30
Second, existing GLP-1 medications like semaglutide already have approval for type 2 diabetes, so retatrutide would be entering a market with established competitors but potentially superior efficacy